Sharekhan

Innova Captab Ltd

Mon 16/02/2026,15:58:44 | NSE : INNOVACAP

₹ 672.75-6.10 (-0.90%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 678.85

Previous Close

₹ 678.85

Volume

139609

Mkt Cap ( Rs. Cr)

₹3849.81

High

₹ 688.80

Low

₹ 670.00

52 Week High

₹ 1020.70

52 Week Low

₹ 624.00

Book Value Per Share

₹ 178.44

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Innova Captab Ltd

Your Vote -

Buy

60.00%

Hold

0.00%

Sell

40.00%

60.00%

10 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

672.75

21

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

21

Option Chain

Analyzes market sentiment, predicts Innova Captab Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Feb 2026, 4:58PM Innova Captab Limited has informed the Exchange about Schedule of meet
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Feb 2026, 4:48PM Innova Captab Limited has informed the Exchange about Transcript
  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    2 Feb 2026, 4:59PM Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
  • Innova Captab - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    2 Feb 2026, 4:52PM Transcript of the Investor/Analyst Earnings Call held on 27th January, 2026:\r\nThis is in continuation to our letter dated 27th January, 2026, wherei
  • Innova Captab - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    2 Feb 2026, 4:50PM Transcript of the Investor/Analyst Earnings Call held on 27th January, 2026:\r\nThis is in continuation to our letter dated 27th January, 2026, wherei
  • Innova Captab - Communication To The Shareholders Of The Company Regarding Deduction Of Tax At Source ('TDS') On Interim Divi

    27 Jan 2026, 6:29PM Pursuant to Finance Act, 2020 with effect from 01st April, 2020, dividend income is taxable in the hands of shareholders. In view of the same, please
  • Innova Captab - Updates

    27 Jan 2026, 6:25PM Innova Captab Limited has informed the Exchange regarding 'Communication to the Shareholders of the Company regarding Deduction of Tax at Source (TDS)
  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    27 Jan 2026, 6:13PM Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Lis
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Jan 2026, 6:06PM Innova Captab Limited has informed the Exchange about Link of Recording
  • Innova Captab has declared 20% Interim dividend for the financial year March 2026

    23 Jan 2026, 10:30PM Innova Captab Ltd. on Monday, 19 January 2026, has announced Interim dividend of 20 percent on Equity Share, to its shareholders holding shares on the
  • Innova Captab - Investor Presentation

    23 Jan 2026, 4:30PM Innova Captab Limited has informed the Exchange about Investor Presentation
  • Innova Captab - Announcement under Regulation 30 (LODR)-Investor Presentation

    23 Jan 2026, 4:30PM Intimation of Investor Presentation for the Analysts/Institutional Investor Meeting to be held on Tuesday, 27th January, 2026 for Financial Results of
  • Innova Captab - Press Release

    23 Jan 2026, 2:59PM Innova Captab Limited has informed the Exchange regarding a press release dated January 23, 2026, titled ""Pursuant to Regulation 30 of the SEBI (List
  • Innova Captab - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    23 Jan 2026, 2:59PM Pursuant to Regulation 30 of SEBI LODR, we are hereby enclosing the press release issued by the Company.
  • Innova Captab Q3 net profit up 14.34% at Rs 27.90 cr

    23 Jan 2026, 2:10PM The company reported standalone net profit of Rs 27.90 crore for the quarter ended December 31, 2025 as compared to Rs 24.40 crore in the same period
  • Innova Captab - Outcome Of The Board Meeting Held Today I.E. 23Rd January, 2026

    23 Jan 2026, 1:42PM Pursuant to Regulation 30 (read with Part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements)
  • Innova Captab - The Company Has Fixed Record Date For The Interim Dividend.

    23 Jan 2026, 1:27PM The Company has announced the record date as 30th January, 2026 for the interim dividend.
  • Innova Captab - Dividend

    23 Jan 2026, 1:14PM Innova Captab Limited has informed the Exchange that Board of Directors at its meeting held on January 23, 2026, declared Interim Dividend of 2 per eq
  • Innova Captab - Corporate Action-Board approves Dividend

    23 Jan 2026, 1:13PM Pursuant to Regulation 30(read with Part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements)
  • Innova Captab - Record Date

    23 Jan 2026, 1:12PM Innova Captab Limited has informed the Exchange that Record date for the purpose of DI is 30-Jan-2026.
  • Innova Captab - Dividend

    23 Jan 2026, 1:09PM Innova Captab Limited has informed the Exchange that Board of Directors at its meeting held on January 23, 2026, declared Interim Dividend of Rs. 2 pe
  • Innova Captab - Outcome of Board Meeting

    23 Jan 2026, 1:06PM Innova Captab Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
  • Innova Captab - Board Meeting Outcome for Outcome Of The Board Meeting Held Today 23Rd January 2026

    23 Jan 2026, 1:06PM Pursuant to Regulation 30 (read with Part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements)
  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    19 Jan 2026, 6:48PM Pursuant to the Regulation 30 read with Schedule III Part A - Para A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Jan 2026, 6:48PM Innova Captab Limited has informed the Exchange about Schedule of meet
  • Innova Captab - Updates

    19 Jan 2026, 3:16PM Innova Captab Limited has informed the Exchange regarding ' Innova Captab Limited has informed the Exchange regarding ' Innova Captab Limited has info
  • Innova Captab - Corporate Action-Board to consider Dividend

    19 Jan 2026, 3:07PM Pursuant to Regulations 29 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeti
  • Innova Captab - Board Meeting Intimation for Intimation Of Board Meeting

    16 Jan 2026, 7:57PM Innova Captab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and ap
  • Innova Captab has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    7 Jan 2026, 6:20PM As of December 2025, 50.90% is owned by Indian Promoters and 49.10% by Public. <p align=justify> Institutional holds 20.34% (Insurance Companies 1.63%
  • Innova Captab - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2026, 1:02PM Innova Captab Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Innova Captab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 1:01PM Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith a
  • Innova Captab - Trading Window

    29 Dec 2025, 5:35PM Innova Captab Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 20
  • Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Dec 2025, 6:33PM Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requireme
  • Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Dec 2025, 6:33PM Innova Captab Limited has informed the Exchange about Schedule of meet

Key fundamentals

Evaluate the intrinsic value of Innova Captab Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1140.093 964.502 503.507 386.882 184.247
Liabilities 1140.093 964.502 503.507 386.882 184.247
Equity 57.225 57.225 48 12 12
Gross Profit 122.299 107.97 98.529 98.509 54.486
Net Profit 89.47 68.161 57.552 66.178 34.5
Cash From Operating Activities 19.801 111.674 39.279 58.339 41.564
NPM(%) 9.33 7.88 6.7 8.42 8.4
Revenue 958.061 864.929 858.673 785.455 410.662
Expenses 835.762 756.959 760.144 686.946 356.176
ROE(%) 8.76 6.67 5.63 6.48 3.37

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
30 Jan 2026 2 20 0 644.75

Peers

Other companies within the same industry or sector that are comparable to Innova Captab Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 735.95 -1.90 43.70 384.47 301.39 0.68
Lotus Eye Hospital and Institute Ltd 118.73 5.00 383.00 1400.94 3.55 0.00
Vaishali Pharma Ltd 8.06 1.38 0.00 8788.58 3.13 0.00
Astec Lifesciences Ltd 623.15 -2.16 0.00 1321.12 -604.77 0.00

Company Info

Theompany wasincorporated in Mumbai, Maharashtra, as`Harun Health Care Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 3, 2005, issued by the RoC. Thereafter, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on December 26, 2009, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', in order to reflect innovations in the pharmaceutical sector. Consequently, a fresh certificate of incorporation dated February 2, 2010, was issued by the RoC to the Company. Subsequently, the Company was converted from a private limited company to a public limited company, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on July 12, 2018, and consequently, the name of the Company was changed to the present name `Innova Captab Limited', and a fresh certificate of incorporation dated July 26, 2018, was issued by the RoC to the Company.Major events and milestones of the Company :2006- stablished the first manufacturing plant in Baddi, Himachal Pradesh2010- Changed the name of the Company from `Harun Health Care Private Limited' to `Innova Captab Private Limited'- Commenced operations at the cephalosporin block of the plant in Baddi, Himachal Pradesh2013- Crossed ?500.00 million in total revenue- Received the first international accreditation in the form of certificate of good manufacturing practices ("GMP") for all manufacturing activities of the Company in relation to the cephalosporin products from the Ministry of Medical Services, Republic of Kenya2015- Incorporated Univentis Medicare Limited through which we undertake the marketing operations2018- Converted the Company from a private limited company to a public limited company2019- Crossed ?3,000.00 million in total revenue2021- Leased land to establish industrial plant at Samba, Jammu and Kashmir- Acquired land to build state of art research and development centre in Panchkula, Haryana- Acquired the assets and liabilities of Innova Partnership on going concern through slump sale- Acquired Univentis Medicare Limited as a wholly owned subsidiary2023- Acquisition of Sharon Bio-Medicine Limited through the wholly owned subsidiary Univentis Medicare Limited.

Theompany wasincorporated in Mumbai, Maharashtra, as`Harun Health Care Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 3, 2005, issued by the RoC. Thereafter, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on December 26, 2009, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', in order to reflect innovations in the pharmaceutical sector. Consequently, a fresh certificate of incorporation dated February 2, 2010, was issued by the RoC to the Company. Subsequently, the Company was converted from a private limited company to a public limited company, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on July 12, 2018, and consequently, the name of the Company was changed to the present name `Innova Captab Limited', and a fresh certificate of incorporation dated July 26, 2018, was issued by the RoC to the Company.Major events and milestones of the Company :2006- stablished the first manufacturing plant in Baddi, Himachal Pradesh2010- Changed the name of the Company from `Harun Health Care Private Limited' to `Innova Captab Private Limited'- Commenced operations at the cephalosporin block of the plant in Baddi, Himachal Pradesh2013- Crossed ?500.00 million in total revenue- Received the first international accreditation in the form of certificate of good manufacturing practices ("GMP") for all manufacturing activities of the Company in relation to the cephalosporin products from the Ministry of Medical Services, Republic of Kenya2015- Incorporated Univentis Medicare Limited through which we undertake the marketing operations2018- Converted the Company from a private limited company to a public limited company2019- Crossed ?3,000.00 million in total revenue2021- Leased land to establish industrial plant at Samba, Jammu and Kashmir- Acquired land to build state of art research and development centre in Panchkula, Haryana- Acquired the assets and liabilities of Innova Partnership on going concern through slump sale- Acquired Univentis Medicare Limited as a wholly owned subsidiary2023- Acquisition of Sharon Bio-Medicine Limited through the wholly owned subsidiary Univentis Medicare Limited.

Read More

Parent Organisation

Innova Captab Ltd.

Founded

03/01/2005

Managing Director

Mr.Vinay Kumar Lohariwala

NSE Symbol

INNOVACAPEQ

FAQ

The current price of Innova Captab Ltd is ₹ 672.75.

The 52-week high for Innova Captab Ltd is ₹ 688.80 and the 52-week low is ₹ 670.00.

The market capitalization of Innova Captab Ltd is currently ₹ 3849.81. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Innova Captab Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Innova Captab Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Innova Captab Ltd shares.

The CEO of Innova Captab Ltd is Mr.Vinay Kumar Lohariwala, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT